Clinical proteomics in cancer: a short cut between genome mutation and glioma development (2008)
- Autores:
- Autores USP: IZUMI, CLARICE - FMRP ; MARIE, SUELY KAZUE NAGAHASHI - FM ; ROSA, JOSE CESAR - FMRP
- Unidades: FMRP; FM
- Assuntos: BIOQUÍMICA; METABOLISMO DE PROTEÍNA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Abstracts
- Nome do evento: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology (SBBq)
-
ABNT
GIMENEZ, M. et al. Clinical proteomics in cancer: a short cut between genome mutation and glioma development. 2008, Anais.. São Paulo: SBBq, 2008. . Acesso em: 24 abr. 2024. -
APA
Gimenez, M., Oliveira, V. C., Izumi, C., Solano, K. R., Orellana, M. D., Eberlin, E. N., et al. (2008). Clinical proteomics in cancer: a short cut between genome mutation and glioma development. In Abstracts. São Paulo: SBBq. -
NLM
Gimenez M, Oliveira VC, Izumi C, Solano KR, Orellana MD, Eberlin EN, Marie SKN, Rosa JC. Clinical proteomics in cancer: a short cut between genome mutation and glioma development. Abstracts. 2008 ;[citado 2024 abr. 24 ] -
Vancouver
Gimenez M, Oliveira VC, Izumi C, Solano KR, Orellana MD, Eberlin EN, Marie SKN, Rosa JC. Clinical proteomics in cancer: a short cut between genome mutation and glioma development. Abstracts. 2008 ;[citado 2024 abr. 24 ] - Optimization of trypsin digestion and mass spectrometry analysis for shotgun proteomics
- Quantitative proteomics analysis of heat shock proteins involved in unfoldeld protein response in glioblastoma cell lines induced by different drugs
- Evaluation of proliferation and migration of T98G and U87MG cells under EGF stimulus
- Proteomic and functional analysis of glioma cell line under rapamycin mTOR inhibition
- Quantitative proteomics of GBM derived cell line U87MG silenced by SI-RNA-nucleophosmin using iTRAQ
- Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma
- Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines
- A proteomic approach to study tumoral progression of glioma
- Proteomic analysis of low-grade to high-grade astrocytomas
- Correlation of nucleophosmin, CRMP2 and RKIP with tumor progression in astrocytomas
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
